02 December 2022 Lysa
LYSA at ASH 2022
The 64th ASH Annual Meeting and Exposition will be held December 10-13, 202...
19 October 2022 Lysa
Launch of the TRANSCRIPT study
The objective of the TRANSCRIPT study is to know if autotransplantation red...
22 September 2022 Lysa
Publication LYSA dans Nature Medicine | DESCA...
L’article du Pr Emmanuel Bachy à propos de l'étude DESCAR-T vient d’...
23 May 2022 Lysa
LYSA studies presented during 2022 ASCO and E...
2 oral communications an 4 posters presented by LYSA in the program of thes...
16 May 2022 Lysa
Health’s Broadcast Magazine de la santé &#...
The reference health broadcast called Le Magazine de la santé on France 5,...
21 November 2021 Lysa
LYSARC – Review of the 2020 Assessment ...
LYSARC - 2020 Review and outlook for 2021
04 November 2021 Lysa
American Society of Hematology annual meeting...
14 September 2021 Lysa
World Lymphoma Day 2021
08 September 2021 Lysa
LYSA Presentations at the 2021 SFH Congress
26 August 2021 Lysa
6th edition of LYSA days, Rennes 2021
01 June 2021 Lysa
LYSA presentations in June 2021 international...
24 March 2021 Lysa
The LYSA/LYSARC launches the first french aca...
07 January 2021 Lysa
COVID vaccination: LYSA recommendations
The LYSA Group totally recommends vaccination against COVID for patients wi...
04 December 2020 Lysa
The LYSA at ASH 62nd Congress!
24 September 2019 Lysa
5th LYSA Days, Montpellier 2019
Pr Guillaume Cartron received us in Montpellier for the 5th LYSA Days...
19 June 2018 Lysa
LYSA’s RELEVANCE Trial in the Media
Return on the presentation of Franck Morschhauser
08 January 2018 Lysa
4th LYSA Days, Nantes 2018
The 4th LYSA Days Conference will take place from 8th to 10th of February 2...
19 December 2017 Lysa
Follicular Lymphoma: efficacy of Rituximab ma...
These results from the PRIMA study conducted by LYSA...
27 September 2017 Lysa
Lymphome à cellules du manteau
Une immunothérapie après la chimiothérapie prolonge la survie des patien...